About this event
It is with great pleasure that we announce the 5th Barts Aortovascular Symposium. This year, the meeting will take place virtually on the 10th of December 2020.
We are building on the success of previous meeting which will continue to blend science and innovation to highlight the most current advances in both the endovascular and open management of the entire spectrum of aortovascular disease.
This year’s meeting brings together an exceptional national and international faculty in the field, to discuss and share their thoughts and expertise with you.
There will, in addition be an opportunity to share your experiences in an exciting abstract and operative video session.
We look forward to welcoming you to this exciting annual meeting hosted by the Barts Heart Centre in London. We hope you will actively participate in this interactive environment.
Please submit to: email@example.com
CPD points have been applied for from the Royal College of Surgeons of England.
A recording will be available to view on Livestorm after the event if you are unable to attend the live sessions. Pre-registration is required to receive access to the recording at a later date or time.
|08.55 – 09.00||Welcome||Professor Aung Oo|
|Session I: Proximal Aorta and Dissection |
Moderators: Jon R Anderson / Professor Rakesh Uppal
|09.00 – 09.10||New Updates on Valve Sparing Aortic Root Replacement||Ruggero De Paulis|
|09.10 – 09.20||PEARS vs VSRR in Marfans Syndrome||Marjan Jahangiri|
|09.20 – 09.30||Inoperable Type A Dissection – Candidates for endovascular repair?||Martin Czerny|
|09.30 – 09.40||Staged procedures for multilevel aneurysms||Martin Czerny|
|09.40 – 09.50||UK experience of acute aortic syndrome during the COVID pandemic||Ana Lopez-Marco|
|09.50 – 10.20||Panel Discussion||All Faculty|
|Session II: Abstract / Videos |
Moderators:Ben Adams / Ana Lopez-Marco
|10.25 – 11.25||6 x 10 minutes allocations for presentations and questions|
|Session III: Dissection – Root and beyond |
Moderators: Kulvinder Lall / Marjan Jahangiri / Carmelo DiSalvo
|11.30 – 11.40||Role of FET in Type A Aortic Dissection||Davide Pacini|
|11.40 – 11.50||Leipzig experience of the AMDS device||Martin Misfeld|
|11.50 – 12.00||Does adding a root replacement in Type A Dissection provide better outcomes?||Ben Adams|
|12.00 – 12.10||UK experience of FET in Acute Type A Dissection||Geoff Tsang|
|12.10 – 12.20||Role of early TEVAR in aortic dissection||Peter Holt|
|12.20 – 12.30||Endo-Bentall procedure – Is there a role in aortic dissection?||Eric Roselli|
|12.30 – 12.55||Panel Dissection||All Faculty|
|12.55 – 14.00||Lunch|
|Session IV: Aortic Arch |
Moderators: John Yap / Geoff Tsang
|14.00 – 14.10||Evita-Neo: UK experience||Jorge Mascaro|
|14.10 – 14.20||Endovascular options for arch||Donald Adam|
|14.20 – 14.30||FET without circulatory arrest||Marco Di Eusanio|
|14.30 – 14.40||Advances in management of infected aortic grafts||Carlos Mestres|
|14.40 – 15.00||Chronic Dissection of the Arch: Open vs Endovascular (with audience vote)|
|14.40 – 14.50||Endovascular Repair||Eric Roselli|
|14.50 – 15.00||Open Repair||Malakh Shrestha|
|15.00 – 15.30||Panel Discussion||All Faculty|
|Session V: Thoracoabdominal |
Moderators: Aung Oo / Matt Matson
|15.30 – 15.50||Type B Chronic Dissection: Open vs Endovascular (with audience vote)|
|15.30 – 15.40||Open Repair||Anthony Estrera|
|15.40 – 15.50||Endovascular||Tara Mastracci|
|15.50 – 16.00||Open conversion after TEVAR failures||Rana Afifi|
|16.00 – 16.10||Advances in endovascular technology||Colin Bicknell|
|16.10 – 16.20||Endoleak management||Pari Sharma|
|16.20 – 16.30||Image guidance with Cydar in endovascular treatment of TAAA||Tara Mastracci|
|16.30 – 16.40||New advances in spinal cord protection||Christian Etz|
|16.40 – 16.50||Degenerative TAAA - Is there still a role for open surgery in the era of endovascular repair?||Germano Melissano|
|16.50 – 17.20||Panel Discussion||All Faculty|
|17.20 – 17.30||Closing Remarks||Professor Rakesh Uppal|
Terumo Aortic is a global medical device company dedicated to developing solutions for aortic and peripheral vascular disease. Our complete portfolio includes the treatment for thoracic, abdominal and peripheral aneurysms, acute and chronic dissections, and peripheral occlusions.
Share this event